Clinical Trial Update: Evaluate the Efficacy and Safety of INI101 Compared to BOTOX® in Subjects With Moderate to Severe Glabellar Lines. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating INI101 versus BOTOX in adults with moderate to severe glabellar lines has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cosmetic Concern Glabellar Lines

Drugs mentioned

• Botox (OnabotulinumtoxinA)
• INI101

Snippet

Sponsor: INIBIO Co., Ltd. | Conditions: Glabellar Lines | Phase 3 | Status: COMPLETED